Parasitic helminth infections in humans modulate Trefoil Factor levels in a manner dependent on the species of parasite and age of the host.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
10 2021
Historique:
received: 14 06 2021
accepted: 07 10 2021
revised: 28 10 2021
pubmed: 19 10 2021
medline: 21 12 2021
entrez: 18 10 2021
Statut: epublish

Résumé

Helminth infections, including hookworms and Schistosomes, can cause severe disability and death. Infection management and control would benefit from identification of biomarkers for early detection and prognosis. While animal models suggest that Trefoil Factor Family proteins (TFF2 and TFF3) and interleukin-33 (IL-33) -driven type 2 immune responses are critical mediators of tissue repair and worm clearance in the context of hookworm infection, very little is known about how they are modulated in the context of human helminth infection. We measured TFF2, TFF3, and IL-33 levels in serum from patients in Brazil infected with Hookworm and/or Schistosomes, and compared them to endemic and non-endemic controls. TFF2 was specifically elevated by Hookworm infection in females, not Schistosoma or co-infection. This elevation was correlated with age, but not worm burden. TFF3 was elevated by Schistosoma infection and found to be generally higher in females. IL-33 was not significantly altered by infection. To determine if this might apply more broadly to other species or regions, we measured TFFs and cytokine levels (IFNγ, TNFα, IL-33, IL-13, IL-1β, IL-17A, IL-22, and IL-10) in both the serum and urine of Nigerian school children infected with S. haematobium. We found that serum levels of TFF2 and 3 were reduced by infection, likely in an age dependent manner. In the serum, only IL-10 and IL-13 were significantly increased, while in urine IFN-γ, TNF-α, IL-13, IL-1β, IL-22, and IL-10 were significantly increased in by infection. Taken together, these data support a role for TFF proteins in human helminth infection.

Identifiants

pubmed: 34662329
doi: 10.1371/journal.pntd.0009550
pii: PNTD-D-21-00872
pmc: PMC8553090
doi:

Substances chimiques

Interleukin-33 0
TFF2 protein, human 0
TFF3 protein, human 0
Trefoil Factor-2 0
Trefoil Factor-3 0
Tumor Necrosis Factor-alpha 0
Interleukin-10 130068-27-8
Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0009550

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI123173
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI125940
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI095289
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI144572
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM083204
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Int J Epidemiol. 1998 Jun;27(3):530-7
pubmed: 9698148
Gene. 2017 May 30;614:8-14
pubmed: 28122268
Parasitology. 2013 Oct;140(12):1534-46
pubmed: 23552512
Mol Biol Rep. 2011 Oct;38(7):4787-92
pubmed: 21153768
PLoS Pathog. 2012 Feb;8(2):e1002520
pubmed: 22346753
Nat Rev Immunol. 2018 Jan;18(1):62-76
pubmed: 28853443
J Biol Chem. 1993 Mar 25;268(9):6694-702
pubmed: 8454642
Trop Med Health. 2020 Nov 12;48(1):90
pubmed: 33292853
Nat Rev Dis Primers. 2018 Aug 9;4(1):13
pubmed: 30093684
F1000Res. 2018 Oct 23;7:
pubmed: 30416709
Gut. 1999 May;44(5):636-42
pubmed: 10205199
Semin Immunopathol. 2020 Jun;42(3):355-371
pubmed: 32076812
Nutrients. 2016 Jun 07;8(6):
pubmed: 27338454
Peptides. 2004 May;25(5):755-62
pubmed: 15177869
Immunity. 2015 Jul 21;43(1):29-40
pubmed: 26200011
Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):282-7
pubmed: 23248269
Clin Transl Gastroenterol. 2020 Dec;11(12):e00274
pubmed: 33512796
Parasitol Res. 2012 Nov;111(5):1871-7
pubmed: 23052781
Korean J Parasitol. 2020 Apr;58(2):109-119
pubmed: 32418379
Am J Trop Med Hyg. 2018 Oct;99(4):1011-1017
pubmed: 30141396
BMC Public Health. 2013 Jul 01;13:619
pubmed: 23816281
Int J Mol Sci. 2019 May 08;20(9):
pubmed: 31072011
Science. 2012 Jul 27;337(6093):431-5
pubmed: 22837519
Int J Parasitol. 2010 Mar 1;40(3):299-306
pubmed: 19699204
Gut. 2000 Dec;47(6):792-800
pubmed: 11076877
J Pathol. 1994 Aug;173(4):327-32
pubmed: 7965392
Int J Mol Med. 2003 Jul;12(1):3-9
pubmed: 12792801
Annu Rev Physiol. 2017 Feb 10;79:357-380
pubmed: 27992733
Am J Epidemiol. 2012 Feb 1;175(3):210-7
pubmed: 22262640
Am J Pathol. 1993 Mar;142(3):663-8
pubmed: 7681255
Am J Pathol. 2018 May;188(5):1161-1170
pubmed: 29458008
Nat Rev Immunol. 2020 Oct;20(10):603-614
pubmed: 32367051
Biomol Concepts. 2015 Dec;6(5-6):343-59
pubmed: 26479350
Nat Commun. 2019 Sep 27;10(1):4408
pubmed: 31562318
PLoS Negl Trop Dis. 2020 Apr 2;14(4):e0007951
pubmed: 32240157
Inflammation. 2009 Apr;32(2):120-9
pubmed: 19238529
Parasitol Res. 2020 Oct;119(10):3451-3457
pubmed: 32869168
Curr Infect Dis Rep. 2011 Jun;13(3):210-7
pubmed: 21462001
J Immunol. 2012 Sep 15;189(6):3078-84
pubmed: 22896633
Int Arch Allergy Immunol. 2012;158(3):288-98
pubmed: 22398631
Curr Gastroenterol Rep. 2019 Jul 10;21(8):34
pubmed: 31289921
J Exp Med. 2012 Mar 12;209(3):607-22
pubmed: 22329990
Aliment Pharmacol Ther. 2005 Jun 1;21(11):1357-64
pubmed: 15932366
Infect Dis Health. 2019 May;24(2):98-106
pubmed: 30648601
Curr Gastroenterol Rep. 2010 Oct;12(5):319-30
pubmed: 20703838
PLoS Negl Trop Dis. 2019 Feb 15;13(2):e0006591
pubmed: 30768602
BMC Res Notes. 2018 Aug 13;11(1):585
pubmed: 30103797
Cell. 2021 Jan 7;184(1):149-168.e17
pubmed: 33278357
PLoS Pathog. 2012;8(3):e1002605
pubmed: 22479181
PLoS Negl Trop Dis. 2014 Sep 11;8(9):e3164
pubmed: 25211227
Immunity. 2005 Nov;23(5):479-90
pubmed: 16286016
Parasite Immunol. 2014 Sep;36(9):428-38
pubmed: 25201406
Immunity. 2019 Apr 16;50(4):871-891
pubmed: 30995504
PLoS Negl Trop Dis. 2008 Apr 16;2(4):e227
pubmed: 18414649
J Allergy Clin Immunol. 2013 Sep;132(3):639-647
pubmed: 23763976
BJU Int. 2011 Feb;107(4):670-7
pubmed: 20636394

Auteurs

Babatunde Adewale (B)

Public Health Department, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.

Jonathan R Heintz (JR)

University of Pennsylvania, Perlman School of Medicine Biostatistics Analysis Center, Philadelphia, Pennsylvania, United States of America.

Christopher F Pastore (CF)

Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of Amerca.

Heather L Rossi (HL)

Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of Amerca.

Li-Yin Hung (LY)

Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of Amerca.
Department of Medicine, Division of Experimental Medicine, University of California, San Francisco, San Francisco, California, United States of Amerca.

Nurudeen Rahman (N)

Public Health Department, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.

Jeff Bethony (J)

Department of Microbiology, Immunology & Tropical Medicine, George Washington University Medical Center, Washington, District of Columbia, United States of Amerca.

David Diemert (D)

Department of Microbiology, Immunology & Tropical Medicine, George Washington University Medical Center, Washington, District of Columbia, United States of Amerca.

James Ayorinde Babatunde (JA)

Department of Biochemistry & Nutrition, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.

De'Broski R Herbert (DR)

Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, United States of Amerca.
Department of Medicine, Division of Experimental Medicine, University of California, San Francisco, San Francisco, California, United States of Amerca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH